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Purpose: The purpose of this retrospective study was to evaluate the short- to mid-term results of thoracic endovascular aort-
ic repair (TEVAR) in Wonkwang University School of Medicine & Hospital. Methods: Between February 2009 and May 2011, 
8 consecutive patients had undergone endovascular stent-grafting for thoracic aortic diseases. Five patients were treated for 
traumatic thoracic aortic injuries, two patients were treated for thoracic aneurysms and one patient was treated for a pseu-
doaneurysm due to penetrating aortic ulcers. Attempted stent-graft deployment was performed electively in 6 patients and 
emergently in 2. Follow-up was performed at 1-month, 6-month, 1-year, and annually thereafter. Results: Technical success 
rates were achieved in 87.5% and the 30-day mortality rate was 0%. Mean hospital length of stay after TEVAR was 30 days in 
traumatic thoracic aortic injuries and 10 days in thoracic aneurismal diseases. Intra-operative Type I endoleak due to migra-
tion at deflation was visualized in 1 patient, which was treated by insertion of another stent-graft. During follow-up, a major 
complication was encountered in one patient who received carotid-subclavian bypass to relieve left arm ischemia. After 5 
months he was treated with arch replacement for aortic arch aneurysm with type I endoleak at proximal site after endovas-
cular treatment. The 30-day mortality rate was 0%. However, 1 case of mortality (12.5%) was observed during the follow-up 
period. Conclusion: The short and mid-term results of endovascular repair of thoracic aortic diseases are promising. TEVAR 
is an effective procedure in the management of thoracic aortic diseases.
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INTRODUCTION
Thoracic aortic diseases are often associated with high 
mortality due to the thoracic aorta’s tendency to rupture. 
The pathophysiology of thoracic aortic disease is complex 
and is as of yet not fully understood. These diseases in-
clude aneurysms, dissections, traumatic injuries, intra-
mural hematomas and penetrating at herosclerotic ulcers. 
A successful treatment using segmental resection and 
graft replacement reported by Cooley and DeBakey [1], 
has been considered the standard treatment in most cases. 
But, regardless of significant advances in the past decades 
to improve surgical techniques and postoperative man-
agement, perioperative mortality and morbidity rates still Thoracic endovascular aortic repair
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Demographic No. (%)
Gender
  Male  4 (50.0)
  Female  4 (50.0)
Medical conditions 
  Ischemic heart disease  0 (0)
  Renal impairment  1 (12.5)
  Hypertension  4 (50.0)
  Diabetes  2 (25.0)
  Chronic pulmonary disease  1 (12.5)
  Cerebrovascular disease  2 (25.0)
Table 1. Patient’s demographics and co-morbid medical conditions
Etiology No.
Aortic aneurysm (atherosclerotic/degenerative)  2
Pseudoaneurysm by penetrating ulcer  1
Traumatic aortic tear and pseudoaneurysm  5
Table 2. Etiology
remains high [2,3]. As an alternative treatment, thoracic 
endovascular aortic repair (TEVAR) is a minimally in-
vasive, safe treatment for descending thoracic disease that 
was first described in 1994 when Dake et al. [4] reported in 
a prospective study that they successfully placed stent 
graft systems via the femoral artery to repair descending 
thoracic aortic aneurysms. Since then, many stent grafts 
have been commercially available for use in thoracic aortic 
disease as an alternative to open surgery. Although initial 
reports on the endovascular stent-graft strategy were en-
couraging in various pathologies, randomized data are 
relatively scarce and until now since the procedure has 
limited data of long-term surveillance. The purpose of this 
retrospective study was to evaluate the short- to mid-term 
results of the TEVAR and to present an overview of our ex-
perience with TEVAR in the treatment of thoracic aortic le-
sions in Wonkwang University School of Medicine & 
Hospital.
METHODS
A retrospective review of eight patients who underwent 
TEVAR in Wonkwang University School of Medicine & 
Hospital between February 2009 and May 2011 was 
conducted. Medical records and radiographic imaging in-
formation were reviewed to determine the indications, 
demographic and co-morbid information, procedural 
techniques, complications, and outcomes. Short and 
mid-term follow-ups were carried out by outpatient clin-
ical review and radiographic imaging with a mean 21.7 
months follow-up period (6 to 36 months). Patient se-
lection was based on consensus by an endovascular sur-
geon, a cardiothoracic surgeon and an interventional car-
diologist for both elective and emergency cases. Diagnosis 
and planning for endovascular repair were made on the 
basis of computed tomography. Four patients received 
Valiant Thoracic stent graft (Medtronic Inc., Minneapolis, 
MN, USA) and four patients received S&G Seal device 
(S&G Inc., Seoul, Korea). Major TEVAR-related complica-
tions, in particular, endoleaks and deaths, were docu-
mented.
RESULTS
Within the study period, 8 patients underwent TEVAR. 
Patient demographics and related co-morbid medical ill-
nesses of this study group are outlined in Table 1. There 
were degenerative/atherosclerotic aneurysm (n = 2), pseu-
doaneurysm by giant penetrating ulcer (n = 1), traumatic 
aortic injury with pseudoaneurysm (n = 5) (Table 2). The 
mean age of the patients was 55.25 years (range, 18 to 83 
years), with 4 men and 4 women. Primary technical suc-
cess, defined as successful deployment and exclusion of 
the lesion without evidence of type I or type III endoleak, 
was achieved in 7 (87.5%) out of 8 patients and the 30-day 
mortality rate was 0%. The left subclavian artery was cov-
ered in 2 patients (25%). There was no incidence of upper 
limb ischemia or posterior circulation insufficiency. No 
prophylactic or therapeutic spinal drainage was per-
formed, and there was no paraparesis or paraplegia due to 
ischemia of the spinal cord. Perioperative endoleak was vi-
sualized in 2 patients (Table 2). They were both type I 
endoleaks. One was treated by insertion of an additional 
stent-graft. The second patient who underwent car-
otid-subclavian bypass simultaneously for protection of Kyung Yun Kim, et al.
304 thesurgery.or.kr
Major complication No. (%)
Mortality 0 (0)
Cardiac arrest 0 (0)
Stroke 0 (0)
Paraplegia 0 (0)
Access site hematoma 1 (12.5)
Hemothorax 1 (12.5)
Pneumonia 1 (12.5)
Pleural effusion 1 (12.5)
Table 3. Postoperative major complications
left arm ischemia, developed an aortic arch aneurysm with 
type I endoleak at proximal site after 5 months follow-up. 
He was treated with arch replacement through surgical 
treatment. Mean hospital length of stay post-TEVAR was 
30 days in traumatic thoracic aortic injuries and 10 days in 
thoracic aneurismal diseases. The 30-day mortality rate 
was 0% and mortality rate during the follow-up period 
was 12.5%. Mortality in this patient was not directly re-
lated to the TEVAR procedure. 
DISCUSSION
The use of endovascular stent grafts in the treatment of 
thoracic aortic diseases is a promising alternative to open 
surgical repair. Especially, blunt aortic injury is associated 
in 20% of cases of motor vehicle accidents and with a possi-
ble pre-hospital mortality rate of between 80% and 90% 
[5]. Recently, a comparative meta-analysis reviewed out-
comes of 699 patients referred for endovascular or open re-
pair after traumatic aortic trans-sections. With a technical 
success rate not different to open repair (96.5% vs. 98.5%, 
P = 0.58), endovascular therapy (n = 370) was associated 
with lower periprocedural mortality (7.6% vs. 15.2%; P = 
0.076), a lower incidence of paraplegia (0% vs. 5.6%; P ＜ 
0.001) and stroke (0.85% vs. 5.3%, P = 0.0028) [6-13] and 
solved most life-threatening problems in aortic trans- 
sections. Findings from our experience confirm that 
TEVAR for traumatic aortic injuries is a feasible option in 
our hospital and the first choice for most trauma patients 
with suitable anatomy and high-risk for open surgical re-
pair, regardless of their age. We successfully deployed 
stent graft in nearly all the patients within our study 
group, with 1 case (12.5%) of early perioperative endoleak. 
These rates are in line with published data of a range be-
tween 16.7% and 30.0% [13-16]. There was no periproce-
dural mortality but one patient required conversion to 
open surgery. There have been questions raised about the 
durability of early thoracic-aortic stent grafts over longer 
periods of follow-up, with Demers et al. [14] reporting ac-
tuarial freedom from treatment failure of 67%, 56% and 
39% at 1, 5 and 8 years, respectively. Although findings 
from our data have been promising, the aneurysmal 
change with type I endoleak of stent graft proximal site in 
one case will need further discussion. Patency of these 
stent grafts is reflected by the endoleak rate of 12.5% over 
a longer period of follow-up, with the study group being 
followed up for an average of 21.7 months. This compares 
favorably with a recent large prospective study involving 
457 patients by Fattori et al. [15] where they reported endo-
leak rates of 8.5% over an average of 24 months.
However, durability of the stent grafts over the lifetime 
of the patient still remains unanswered. Because of this, 
the need for lifetime imaging surveillance in these patients 
becomes an economic and logistic issue. Due to the retro-
spective nature of the study, there is large variation in the 
follow-up length with a standard deviation of 19 months 
within the group.
Paraplegia from spinal ischemia is one of the most seri-
ous and well-described complications of TEVAR, with 
most studies reporting incidence rates ranging from 0 to 
3% [13-16]. It is not known which effect of TEVAR results 
in paraplegia, but Dialetto et al. [16] have suggested that 
the coverage of intercostal arteries, embolic events, blood 
loss, or insufficient collateral circulation may be related to 
it. There is good evidence in the use of lumbar spinal 
drains in thoracoabdominal aortic surgery [17], with the 
available literature supporting the use in TEVAR, espe-
cially in selective high-risk patients [18]. We did not ob-
serve any case of paraplegia though we did not perform 
any prophylactic spinal drains in our cases, but our results 
are limited by the small sample size (Table 3). There is no 
procedure-related mortality within our study group. 
However, the wide range of pathologies and the variety of 
patient's premorbid state, along with the limitation of a 
small study cohort preclude such assessments in our Thoracic endovascular aortic repair
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series. Hence, even with the outstanding technical ad-
vancement with regard to the design and manufacture of 
current devices, longer term follow-up and additional im-
provements are essential before TEVAR becomes the 
standard of care. The true potential of TEVAR in the vari-
ous aortic diseases should be studied in a large random-
ized study.
Endovascular treatment for thoracic aortic diseases pro-
vides clinicians and patients with an alternative to the sig-
nificant morbidity and mortality of open surgical proce-
dures, but only when used in appropriately selected cases. 
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